Xinbi Li is an accomplished scientist currently serving as an Associate Principal Scientist at AstraZeneca since August 2023. Previously, Xinbi co-founded Helithium LLC and held various roles at AbbVie, including Chemist III, where significant contributions included developing advanced assay methods for the analysis of lipases, proteases, and amylases in pancrelipase mixtures. At Dragonfly Therapeutics, Inc., Xinbi advanced to Chemist IV and Senior Scientist, leading projects in antibody discovery and perform predevelopability assessments for drug candidates. Xinbi holds a PhD in Chemistry from Worcester Polytechnic Institute and a BS in Pharmaceutical Sciences from Fudan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices